Brief: Immix Biopharma Files For Mixed Shelf Of Up To $250 Mln
03/01/2023 21:20
Jan 3 (Reuters) - Immix Biopharma Inc IMMX.O :
* IMMIX BIOPHARMA INC FILES FOR MIXED SHELF OF UP TO $250
MILLION
- SEC FILING
Source: (https://bit.ly/3Gfzc9e)
Further company coverage: IMMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immix Biopharma
See all newsBrief: Immix Biopharma Announces Closing Of $125 Million Underwritten Offering Of Common Stock
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Brief: Immix Biopharma Announces Pricing Of $125 Million Underwritten Offering Of Common Stock
Brief: Immix Biopharma Announces 89% Complete Response Rate At Interim Update Across All Nexicart-2 Patients, With Mrd-Negativity Indicating Potential To Reach Up To 98% Complete Response Rate
Immix Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary